Chr. Hansen's probiotic experts to participate at Vitafoods 2011

Chr. Hansen's probiotic experts to participate at Vitafoods 2011

Chr. Hansen’s probiotics experts participate at the leading nutraceuticals trade show in Europe—Vitafoods taking place in Geneva. In addition, Chr. Hansen is shortlisted for two Nutraceutical Business & Technology Awards (NBTA) at Vitafoods.

Chr. Hansen’s probiotics experts participate at the leading nutraceuticals trade show in Europe—Vitafoods taking place in Geneva, Switzerland May 10-12, 2011.

“At this year’s Vitafoods we will be showcasing our ‘BB-12® plus fiber’ concept against constipation. The combination builds on strong clinical studies on BB-12® and the historical beneficial effect of fibers on constipation,” says Charlotte Beyerholm, Marketing Manager, Human Health & Nutrition.

On Wednesday May 11 at 15.10 o’clock, Chr. Hansen will be hosting a Vitafoods seminar about the concept.

“Visitors at our booth may also try some of our samples of probiotic sticks and chewable tablets in various flavors: strawberry, vanilla, peppermint and orange,” says Charlotte Beyerholm.

Award finalist

Chr. Hansen is shortlisted for two Nutraceutical Business & Technology Awards (NBTA) at Vitafoods:

• Most Effective Strategic Product Development

• Most Improved Product Safety and Quality

In the first category, the NBTA judges have selected the Chr. Hansen nomination “BB 12® plus fiber for constipation” as finalist for the award. In the second category, Chr. Hansen’s “Development of infant formula grade probiotic ingredients” is a finalist. The NBTA winners will be announced on May 11 at the Starling Geneva Hotel & Conference Centre.

Meet Chr. Hansen’s probiotic experts at booth no. 518 in the Geneva Palexpo exhibit hall, and learn how we can help improve your business.

www.chr-hansen.com/vitafoods2011

www.chr-hansen.com/probiotics

http://www.vitafoods.eu.com

About Chr. Hansen

Chr. Hansen is a global bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. All solutions are based on strong research and development competencies and significant technology investments. Revenue in FY2009/10 was EUR 576 million. The company enjoys market leadership in all its divisions: Cultures & Enzymes, Health & Nutrition and Colors & Blends. There are more than 2,300 dedicated employees in over 30 countries. Chr. Hansen, which was founded in 1874, is listed on the NASDAQ OMX stock exchange in Copenhagen, Denmark. For further information, please visit www.chr-hansen.com.

Hide comments

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish